Interleukin 6(-174G/C) variant and its circulating levels in coronary artery disease patients and their first degree relatives

Inflammation

Volumn 37, Issue 2, 2014, Pages 314-321

  Galimudi, Rajesh Kumar ^a   Spurthi, Mrudula K ^a   Padala, Chiranjeevi ^a   Kumar, Kishore G ^a   Mudigonda, Saraswati ^a   Reddy, Srilatha G ^a   Aiyengar, Mohini T ^a   Sahu, Sanjib K ^b   Rani, Surekha H ^a  

^a OSMANIA UNIVERSITY   (India)

^b Durgabai Deshmukh Hospital and Research Centre   (India)

Author keywords

C reactive protein (CRP); coronary artery disease (CAD); first degree relatives (FDRs); genotyping; interleukin 6 (IL 6)

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MIDDLE AGED; PATHOGENESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84896384714     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9742-8     Document Type: Article

References (32)

1. Svati, H.S.; J.F. Neil, Lisheng, R.C. David, H.S. David, H. Carol, J. Jessica, N. Sarah, W. Liyong, J.C. Jessica, M. Michael, S.G. Geoffrey, C.C. David, J.H.J. Christopher, V. Jeffery, H.S.J. Michael, B.G. Christopher, B.N. Christopher, G.G. Simon, J.G.C. Pascal, E.K. William, and R.H. Elizabeth. 2009. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genetics 5(1): e1000318.
2. Rajeshwari, R.R.; T.A. Nicklas, H.J. Pownall, and G.S. Berenson. 2005. Cardiovascular diseases - A major health risk in Asian Indians. Nutrition Research 25: 515-533.
3. Apurva, S.; M. Ranjit, S. Swarup, R. Rani, D. Gargi, R. Himanshu, D. Shoba, S. Aarti, D. Pradnya, T. Seema, and F.A. Tester. 2011. Prevalence of metabolic syndrome in urban India. Hindawi Publishing Corporation, Cholesterol. Volume, Article ID 920983, 7 pp.
4. Kasliwal, R.R.; A. Kulshreshtha, S. Agrawal, M. Bansal, and N. Trehan. 2006. Prevalence of cardiovascular risk factors in Indian patients undergoing coronary artery bypass surgery. JAPI 54: 371-375.
5. Yeh, E.T.H.; H.V. Anderson, V. Pasceri, and J.T. Willerson. 2001. C-reactive protein linking inflammation to cardiovascular complications. Circulation 104: 974-975.
6. Ross, R. 1999. Atherosclerosis: An inflammatory disease. New England Journal of Medicine 340: 115-126.
7. Sven, W.; S. Michaela, S. Kerstin, S. Andreas, S. Bernhard, B. Michael, and N. Georg. 2004. Interleukin-6 induces oxidative stress and endothelial; dysfunction by overexpression of the angiotensin II type 1 receptor. Circulation Research 94: 534-541.
8. Armstrong, E.J.; D.A. Morrow, and M.S. Sabatine. 2006. Inflammatory biomarkers in acute coronary syndromes: Part I. Introduction and cytokines. Circulation 113: e72-e75.
9. Bennermo, M.; C. Held, S. Stemme, C.G. Ericsson, A. Silveira, F. Green, and P. Tornvall. 2004. Genetic predisposition of the interleukin-6 response to inflammation: Implications for a variety of major diseases? Clinical Chemistry 50(11): 2136-2140.
10. Lahiri, D.; and J. Nurnberger. 1991. A rapid non enzymatic method for preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 19: 5444.
11. Ross, R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 802-809.
12. Woods, D.J.B.; S.E. Humphries, and H.E. Montgomery. 2000. Genetics of inflammation and risk of coronary artery disease: The central role of interleukin-6. European Heart Journal 21: 1574-1583.
13. Connelly, J.J.; T. Wang, J.E. Cox, C. Haynes, L. Wang, S.H. Shah, D.R. Crosslin, A.B. Hale, S. Nelson, D.C. Crossman, C.B. Granger, J.L. Haines, C.J.H. Jones, J.M. Vance, P.J. Goldschmidt-Clermont, W.E. Kraus, E.R. Hauser, and S.G. Gregory. 2006. GATA2 is associated with familial early-onset coronary artery disease. PLoS Genetics 2(8): e139.
14. Mendall, M.A.; P. Patel, M. Asante, L. Ballam, J. Morris, D.P. Strachan, A.J. Camm, and T.C. Northfield. 1997. Relation of serum levels of cytokines to cardiovascular risk factors and coronary heart disease. Heart 78: 273-277.
15. Luc, G.; J.-M. Bard, I. Juhan-Vague, J. Ferrieres, A. Evans, P. Amouyel, D. Arveiler, J.-C. Fruchart, D. Ducimetiere, and on behalf of the PRIME Study Group. 2003. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. The PRIME Study. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 1255-1261.
16. Humphries, S.E.; L.A. Luong, M.S. Ogg, E. Hawe, and G.J. Miller. 2001. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. European Heart Journal 22: 2243-2252.
17. Ridker, P.M.; J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens. 1998. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98: 731-733.
18. Bo, I.M.; A.S. Raspo, E. Morra, G. Isaia, M. Cassader, E. Fabris, and L. Poli. 2004. Body fat and C-reactive protein levels in healthy non-obese men. Nutrition, Metabolism, and Cardiovascular Diseases 14: 66-72.
19. Koenig, W.; M. Sund, M. Frohlich, H.G. Fischer, H. Lowe, A. Doring, W.L. Hutchinson, and M.B. Pepys. 1999. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99: 237-242.
20. Yudkin, J.S.; C.D.A. Stehouwer, J.J. Emeis, and S.W. Coppack. 1999. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 19: 972-978.
21. Josemanuel, F.R.; V. Montserrat, R. Cristobal, G. Cristina, B. Montserrat, V. Joan, and R. Wifredo. 2001. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. Journal of Clinical Endocrinology and Metabolism 86: 1154-1159.
22. Dimitris, A.P.; L.W. Ronald, C.M. Stavros, and P.C. George. 1998. The pathophysiologic roles of interleukin-6 in human disease. Annals of Internal Medicine 128: 127-137.
23. Aukrust, P.; T. Ueland, E. Lien, et al. 1999. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 83: 376-382.
24. Liu, Y.; S.Y. Berthier, M.D. Fallin, N.E. Fink, R.P. Tracy, and M.J. Klag. 2006. IL-6 Haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. Journal of the American Society of Nephrology 17: 863-870.
25. Danesh, J.; K. Stephen, G.M. Andrea, S. Nadeem, W. Angela, B.A. Sara, W. Frances, P.T.H. Julian, L. Lucy, E. Gudny, R. Ann, H.W. Peter, D.O.L. Gordon, and G. Vilmundur. 2008. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Medicine 5(4): e78.
26. Ridker, P.R.; R. Nader, J.S. Meir, and H.H. Charles. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men; atherogenesis. Circulation 101: 1767-1772.
27. Mohlig, M.; B. Heiner, S. Joachim, O. Martin, K. Anja, E.V.A. Fisher, M.B. Manuela, R. Michael, H. Kurt, and F.H.P. Andreas. 2004. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 89: 1885-1890.
28. Jones, K.G.; D.J. Brull, M. Sian, L.C. Brown, S.E. Humphries, and J.T. Powell. 2001. Interleukin-6 and the prognosis of abdominal aortic aneurysm. Circulation 103: 2260-2265.
29. Georges, J.L.; V. Loukaci, O. Poirier, A. Evans, G. Luc, D. Arveiler, J.B. Ruidavets, F. Cambien, and L. Tiret. 2001. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: The ECTIM study. Journal of Molecular Medicine 79: 300-305.
30. Terry, C.F.; V. Loukaci, and F.R. Green. 2000. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. Journal of Biological Chemistry 275: 18138-18144.
31. Fishman, D.; G. Faulds, R. Jeffery, V. Mohamed-Ali, J.S. Yudkin, S. Humphries, et al. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation 102: 1369-1376.
32. Roger, R.W.; C.H. Steven, H. Gerardo, A.P. Michael, T.B. Jeannette, H. Millicent, M.C. Robert, W. Joan, and N.H. Paul. 2001. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research. (The Health Family Tree Study and the NHLBI Family Heart Study). American Journal of Cardiology 87: 129-135.